INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44 | -67.2% | 16,600 | -40.3% | 0.00% | -77.8% |
Q2 2023 | $134 | +204.5% | 27,800 | +183.7% | 0.02% | +350.0% |
Q1 2023 | $44 | -99.9% | 9,800 | +25.6% | 0.00% | 0.0% |
Q3 2022 | $49,000 | – | 7,800 | +271.4% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 2,100 | -90.1% | 0.00% | -100.0% |
Q1 2020 | $221,000 | +215.7% | 21,293 | +90.1% | 0.01% | +71.4% |
Q4 2018 | $70,000 | +48.9% | 11,200 | -20.6% | 0.01% | +75.0% |
Q3 2018 | $47,000 | 0.0% | 14,100 | +193.8% | 0.00% | +33.3% |
Q2 2018 | $47,000 | +6.8% | 4,800 | +41.2% | 0.00% | +50.0% |
Q4 2017 | $44,000 | -93.7% | 3,400 | -95.1% | 0.00% | -92.3% |
Q3 2017 | $696,000 | +1320.4% | 68,739 | +413.0% | 0.03% | +1200.0% |
Q2 2017 | $49,000 | -73.9% | 13,400 | -85.8% | 0.00% | -71.4% |
Q1 2017 | $188,000 | +1988.9% | 94,265 | +366.7% | 0.01% | – |
Q4 2016 | $9,000 | -62.5% | 20,200 | -30.6% | 0.00% | -100.0% |
Q3 2016 | $24,000 | -7.7% | 29,100 | +41.3% | 0.00% | -50.0% |
Q2 2016 | $26,000 | +62.5% | 20,600 | +8.4% | 0.00% | – |
Q1 2016 | $16,000 | -89.1% | 19,000 | -36.0% | 0.00% | -100.0% |
Q4 2015 | $147,000 | – | 29,667 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |